170 related articles for article (PubMed ID: 21576491)
1. In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract.
Fuhrmann G; Leroux JC
Proc Natl Acad Sci U S A; 2011 May; 108(22):9032-7. PubMed ID: 21576491
[TBL] [Abstract][Full Text] [Related]
2. Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy.
Gass J; Ehren J; Strohmeier G; Isaacs I; Khosla C
Biotechnol Bioeng; 2005 Dec; 92(6):674-84. PubMed ID: 16136593
[TBL] [Abstract][Full Text] [Related]
3. Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue.
Shan L; Marti T; Sollid LM; Gray GM; Khosla C
Biochem J; 2004 Oct; 383(Pt 2):311-8. PubMed ID: 15245330
[TBL] [Abstract][Full Text] [Related]
4. Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase.
Alvarez-Sieiro P; Martin MC; Redruello B; Del Rio B; Ladero V; Palanski BA; Khosla C; Fernandez M; Alvarez MA
Appl Microbiol Biotechnol; 2014 Aug; 98(15):6689-700. PubMed ID: 24752841
[TBL] [Abstract][Full Text] [Related]
5. Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity.
Shan L; Mathews II; Khosla C
Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3599-604. PubMed ID: 15738423
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the allosteric mechanisms of prolyl endopeptidases for celiac disease therapy: Insights from molecular dynamics simulations.
Wang Y; Xing S; Zhao X; Chen X; Zhan CG
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129313. PubMed ID: 38216012
[TBL] [Abstract][Full Text] [Related]
7. Prolyl endopeptidases.
Gass J; Khosla C
Cell Mol Life Sci; 2007 Feb; 64(3):345-55. PubMed ID: 17160352
[TBL] [Abstract][Full Text] [Related]
8. Gluten Degrading Enzymes for Treatment of Celiac Disease.
Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.
Stepniak D; Spaenij-Dekking L; Mitea C; Moester M; de Ru A; Baak-Pablo R; van Veelen P; Edens L; Koning F
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G621-9. PubMed ID: 16690904
[TBL] [Abstract][Full Text] [Related]
10. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides.
Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C
PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975
[TBL] [Abstract][Full Text] [Related]
11. Bile acids as modulators of enzyme activity and stability.
Robic S; Linscott KB; Aseem M; Humphreys EA; McCartha SR
Protein J; 2011 Dec; 30(8):539-45. PubMed ID: 21965022
[TBL] [Abstract][Full Text] [Related]
12. Rationally engineered prolyl endopeptidases from Sphingomonas capsulata with improved hydrolytic activity towards pathogenic peptides of celiac diseases.
Xiao B; Zhang C; Song X; Wu M; Mao J; Yu R; Zheng Y
Eur J Med Chem; 2020 Sep; 202():112499. PubMed ID: 32668378
[TBL] [Abstract][Full Text] [Related]
13. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.
Mitea C; Havenaar R; Drijfhout JW; Edens L; Dekking L; Koning F
Gut; 2008 Jan; 57(1):25-32. PubMed ID: 17494108
[TBL] [Abstract][Full Text] [Related]
14. Rational design of combination enzyme therapy for celiac sprue.
Siegel M; Bethune MT; Gass J; Ehren J; Xia J; Johannsen A; Stuge TB; Gray GM; Lee PP; Khosla C
Chem Biol; 2006 Jun; 13(6):649-58. PubMed ID: 16793522
[TBL] [Abstract][Full Text] [Related]
15. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.
Gass J; Bethune MT; Siegel M; Spencer A; Khosla C
Gastroenterology; 2007 Aug; 133(2):472-80. PubMed ID: 17681168
[TBL] [Abstract][Full Text] [Related]
16. A propeptide toolbox for secretion optimization of Flavobacterium meningosepticum endopeptidase in Lactococcus lactis.
Lim PY; Tan LL; Ow DS; Wong FT
Microb Cell Fact; 2017 Dec; 16(1):221. PubMed ID: 29207979
[TBL] [Abstract][Full Text] [Related]
17. Protein engineering of improved prolyl endopeptidases for celiac sprue therapy.
Ehren J; Govindarajan S; Morón B; Minshull J; Khosla C
Protein Eng Des Sel; 2008 Dec; 21(12):699-707. PubMed ID: 18836204
[TBL] [Abstract][Full Text] [Related]
18. Development of wheat genotypes expressing a glutamine-specific endoprotease from barley and a prolyl endopeptidase from Flavobacterium meningosepticum or Pyrococcus furiosus as a potential remedy to celiac disease.
Osorio CE; Wen N; Mejias JH; Liu B; Reinbothe S; von Wettstein D; Rustgi S
Funct Integr Genomics; 2019 Jan; 19(1):123-136. PubMed ID: 30159724
[TBL] [Abstract][Full Text] [Related]
19. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
[TBL] [Abstract][Full Text] [Related]
20. Influence of dietary components on Aspergillus niger prolyl endoprotease mediated gluten degradation.
Montserrat V; Bruins MJ; Edens L; Koning F
Food Chem; 2015 May; 174():440-5. PubMed ID: 25529703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
